Cencora reports fourth-quarter EPS of $2.71

Cencora reported fourth-quarter earnings of $2.71 a share. The report carried the per-share figure alone, with no revenue line, guidance, or year-earlier base, so the result cannot yet be measured against expectations. Cencora is one of the largest US pharmaceutical distributors, and its quarterly print is a read on drug volumes, generic pricing, and specialty distribution economics.